Viewing Study NCT07455851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-05-05 @ 11:48 AM
Study NCT ID: NCT07455851
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-06
First Post: 2026-03-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Refractory Multiple Myeloma (RRMM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell maturation antigen (BCMA) View
None Anti-CD3 monoclonal antibodies (mAbs) View
None G-protein-coupled receptor class C group 5 member D (GPRC5D) View